Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antineoplastic Combined Chemotherapy Protocols administration & dosage"" wg kryterium: Temat


Tytuł:
Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports
Autorzy:
Haithem Chtioui
Laura Marino
Marco Zezza
Carine Mekoguem
Christophe Kosinski
Nelly Pitteloud
Faiza Lamine
Pokaż więcej
Temat:
Immune checkpoint inhibitor
Autoimmune adverse events
Endocrinopathies
Type 1 diabetes
lcsh:Diseases of the endocrine glands. Clinical endocrinology
lcsh:RC648-665
Case Report
General Medicine
Endocrinology, Diabetes and Metabolism
Oncology
medicine.medical_specialty
medicine
Type 2 Diabetes Mellitus
Combination therapy
Type 2 diabetes
medicine.disease
business.industry
business
Ipilimumab
medicine.drug
Nivolumab
Diabetic ketoacidosis
Diabetes mellitus
Internal medicine
Acute Disease
Aged, 80 and over
Antineoplastic Agents, Immunological/administration & dosage
Antineoplastic Agents, Immunological/adverse effects
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Diabetes Mellitus, Type 1/chemically induced
Diabetes Mellitus, Type 1/diagnosis
Diabetes Mellitus, Type 1/pathology
Female
Humans
Ipilimumab/administration & dosage
Ipilimumab/adverse effects
Male
Melanoma/drug therapy
Melanoma/pathology
Middle Aged
Nivolumab/administration & dosage
Nivolumab/adverse effects
Skin Neoplasms/drug therapy
Skin Neoplasms/pathology
Źródło:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Endocrine Disorders
BMC endocrine disorders, vol. 19, no. 1, pp. 144
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a722f98fa2436ff73199210f96e9153
https://doaj.org/article/5e85b5b762c841489b8519ccf9b5cc94
Tytuł:
A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours
Autorzy:
Karl Hsu
Jan H.M. Schellens
Sandrine Macé
Gilles Tuffal
Martijn P. Lolkema
Andrea Varga
Maja J.A. de Jonge
Samantha Goodstal
Vincent A. de Weger
Koruth Thomas
Brigitte Demers
Eric Deutsch
Marlies H.G. Langenberg
Pokaż więcej
Temat:
Article
Targeted therapies
Outcomes research
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Dose-Response Relationship, Drug
Female
Gene Expression Regulation, Neoplastic/drug effects
Humans
Indoles/administration & dosage
MAP Kinase Kinase Kinases/antagonists & inhibitors
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms/classification
Niacinamide/administration & dosage
Protein Kinase Inhibitors/administration & dosage
Proto-Oncogene Proteins B-raf/genetics
Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors
Proto-Oncogene Proteins p21(ras)/genetics
Spiro Compounds/administration & dosage
Thrombocytopenia/chemically induced
Tumor Suppressor Protein p53/genetics
Dose-Response Relationship
Drug
Gene Expression Regulation
Neoplastic/drug effects
Cancer Research
Oncology
Toxicity
Medicine
business.industry
business
Vomiting
medicine.symptom
Internal medicine
medicine.medical_specialty
Antagonist
Pharmacokinetics
MEK inhibitor
Combination therapy
Adverse effect
Gastroenterology
Nausea
Źródło:
British Journal of Cancer
British Journal of Cancer, 120(3), 286
Opis pliku:
image/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c753c193b29e94b1383adbb0c16bd68
http://europepmc.org/articles/PMC6354023
Tytuł:
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
Autorzy:
Dohan, Anthony
Gallix, Benoit
Guiu, Boris
Le Malicot, Karine
Reinhold, Caroline
Soyer, Philippe
Bennouna, Jaafar
Ghiringhelli, Francois
Barbier, Emilie
Boige, Valérie
Taieb, Julien
Bouché, Olivier
François, Eric
Phelip, Jean-Marc
Borel, Christian
Faroux, Roger
Seitz, Jean-Francois
Jacquot, Stéphane
Ben Abdelghani, Meher
Khemissa-Akouz, Faiza
Genet, Dominique
Jouve, Jean Louis
Rinaldi, Yves
Desseigne, Françoise
Texereau, Patrick
Suc, Etienne
Lepage, Come
Aparicio, Thomas
Hoeffel, Christine
Pokaż więcej
Temat:
Chemotherapy
Clinical decision making
Colorectal cancer
Colorectal metastases
Computerised image analysis
MESH: Adult
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Bevacizumab / administration & dosage
Camptothecin / administration & dosage
MESH: Camptothecin / administration & dosage
Camptothecin / analogs & derivatives
Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / pathology
Computational Biology
Female
MESH: Fluorouracil / administration & dosage
Humans
Kaplan-Meier Estimate
Leucovorin / administration & dosage
Liver Neoplasms / diagnostic imaging
MESH: Liver Neoplasms / secondary
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
MESH: Radiographic Image Interpretation, Computer-Assisted
Response Evaluation Criteria in Solid Tumors
Survival Rate
Tomography, X-Ray Computed
[INFO.INFO-IM]Computer Science [cs]/Medical Imaging
[SDV.CAN]Life Sciences [q-bio]/Cancer
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Gastroenterology
medicine.medical_treatment
medicine
Internal medicine
medicine.medical_specialty
Bevacizumab
medicine.drug
medicine.disease
Oncology
Log-rank test
Prospective cohort study
FOLFIRI
Cohort
Irinotecan
business.industry
business
Źródło:
Gut
Gut, BMJ Publishing Group, 2020, 69 (3), pp.531-539. ⟨10.1136/gutjnl-2018-316407⟩
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8075364a64f6848b3680bb08f7c9c30
https://hal.archives-ouvertes.fr/hal-02483779
Tytuł:
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
Autorzy:
Spicka, Ivan
Ocio, Enrique María
Oakervee, Heather H.E.
Greil, Richard
Banh, Raymond H
Huang, Shang Yi
D'Rozario, James M
Dimopoulos, Meletios Athanassios
Martínez, Sara
Extremera, Sonia
Kahatt, Carmen
Alfaro, Vicente
Carella, Angelo Michele
Meuleman, Nathalie
Hájek, Roman
Symeonidis, Argiris
Min, Chang Ki
Cannell, Paul
Ludwig, Heinz
Sonneveld, Pieter
Mateos, Maria-Victoria
Pokaż więcej
Temat:
Multiple myeloma . Plitidepsin . Dexamethasone . Relapsed . Refractory
Hématologie
Dexamethasone
Multiple myeloma
Plitidepsin
Refractory
Relapsed
Original Article
Hematology
General Medicine
Bortezomib
medicine.drug
medicine
Internal medicine
medicine.medical_specialty
Nausea
medicine.symptom
medicine.disease
Lenalidomide
Thalidomide
business.industry
business
Gastroenterology
Clinical endpoint
Sciences bio-médicales et agricoles
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Bortezomib -- administration & dosage
Depsipeptides -- administration & dosage
Dexamethasone -- administration & dosage
Disease-Free Survival
Female
Humans
Lenalidomide -- administration & dosage
Male
Middle Aged
Multiple Myeloma -- drug therapy -- mortality
Survival Rate
Thalidomide -- administration & dosage
Źródło:
Annals of Hematology, 98(9), 2139-2150
Annals of hematology
Annals of Hematology
Annals of hematology, 98 (9
Opis pliku:
application/pdf; 1 full-text file(s): application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca21caae1db2c673a339baafea4841c
http://hdl.handle.net/1765/121027
Tytuł:
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma:Results From the Phase IIIb/IV CheckMate 511 Trial
Autorzy:
Lebbé, Celeste
Meyer, Nicolas
Mortier, Laurent
Marquez-Rodas, Ivan
Robert, Caroline
Rutkowski, Piotr
Menzies, Alexander M.
Eigentler, Thomas
Ascierto, Paolo A.
Smylie, Michael
Schadendorf, Dirk
Ajaz, Mazhar
Svane, Inge Marie
Gonzalez, Rene
Rollin, Linda
Lord-Bessen, Jennifer
Saci, Abdel
Grigoryeva, Elena
Pigozzo, Jacopo
Pokaż więcej
Temat:
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Disease Progression
Double-Blind Method
Drug Administration Schedule
Female
Humans
Ipilimumab/administration & dosage
Male
Melanoma/drug therapy
Middle Aged
Neoplasm Staging
Nivolumab/administration & dosage
Progression-Free Survival
Skin Neoplasms/drug therapy
Time Factors
Young Adult
Clinical Trial, Phase III
Clinical Trial, Phase IV
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Rapid Communication
Melanoma
Cancer Research
Oncology
Clinical endpoint
Ipilimumab
medicine.drug
medicine
Internal medicine
medicine.medical_specialty
Clinical trial
Nivolumab
Dosing
business.industry
business
Progression-free survival
Randomized controlled trial
law.invention
law
Gastroenterology
Adverse effect
Źródło:
Lebbé, C, Meyer, N, Mortier, L, Marquez-Rodas, I, Robert, C, Rutkowski, P, Menzies, A M, Eigentler, T, Ascierto, P A, Smylie, M, Schadendorf, D, Ajaz, M, Svane, I M, Gonzalez, R, Rollin, L, Lord-Bessen, J, Saci, A, Grigoryeva, E & Pigozzo, J 2019, ' Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma : Results From the Phase IIIb/IV CheckMate 511 Trial ', Journal of Clinical Oncology, vol. 37, no. 11, pp. 867-875 . https://doi.org/10.1200/JCO.18.01998
Journal of Clinical Oncology
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7100d36b125a105d0de169d7144e1e3e
https://curis.ku.dk/ws/files/236508642/jco.18.01998.pdf
Tytuł:
Perioperative chemotherapy for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Autorzy:
Al-Batran, Salah-Eddin
Homann, Nils
Pauligk, Claudia
Goetze, Thorsten O
Meiler, Johannes
Kasper, Stefan
Kopp, Hans-Georg
Mayer, Frank
Haag, Georg Martin
Luley, Kim
Lindig, Udo
Schmiegel, Wolff
Pohl, Michael
Stoehlmacher, Jan
Folprecht, Gunnar
Probst, Stephan
Prasnikar, Nicole
Fischbach, Wolfgang
Mahlberg, Rolf
Trojan, Jörg
Koenigsmann, Michael
Martens, Uwe M
Thuss-Patience, Peter
Egger, Matthias
Block, Andreas
Heinemann, Volker
Illerhaus, Gerald
Moehler, Markus
Schenk, Michael
Kullmann, Frank
Behringer, Dirk M
Heike, Michael
Pink, Daniel
Teschendorf, Christian
Löhr, Carmen
Bernhard, Helga
Schuch, Gunter
Rethwisch, Volker
von Weikersthal, Ludwig Fischer
Hartmann, Jörg T
Kneba, Michael
Daum, Severin
Schulmann, Karsten
Weniger, Jörg
Belle, Sebastian
Gaiser, Timo
Oduncu, Fuat S
Güntner, Martina
Hozaeel, Wael
Reichart, Alexander
Jäger, Elke
Kraus, Thomas
Moenig, Stefan Paul
Bechstein, Wolf O
Schuler, Martin
Schmalenberg, Harald
Hofheinz, Ralf D
FLOT4-AIO Investigators
Pokaż więcej
Temat:
ddc:617
Adenocarcinoma/drug therapy/pathology
Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols/administration & dosage/therapeutic use
Capecitabine/administration & dosage/therapeutic use
Cisplatin/administration & dosage/therapeutic use
Digestive System Surgical Procedures
Disease-Free Survival
Docetaxel/administration & dosage/therapeutic use
Esophagogastric Junction/pathology
Female
Fluorouracil/administration & dosage/therapeutic use
Humans
Leucovorin/administration & dosage/therapeutic use
Male
Middle Aged
Neoplasm Staging
Oxaliplatin/administration & dosage/therapeutic use
Stomach Neoplasms/drug therapy/pathology
Treatment Outcome
digestive system diseases
neoplasms
therapeutics
urologic and male genital diseases
organic chemicals
Źródło:
The Lancet, Vol. 393, No 10184 (2019) pp. 1948-1957
Dostępność:
https://explore.openaire.eu/search/publication?articleId=od______1400::0b9cf264bfe92e55766adcd35c21e6e4
https://archive-ouverte.unige.ch/unige:134616
Tytuł:
Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy
Autorzy:
Salah D. Qanadli
Alban Denys
Stefania Proietti
Thierry de Baere
Bertrand Bessoud
Pierre Schnyder
Francesco Doenz
Pokaż więcej
Temat:
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Duodenal Ulcer/chemically induced
Duodenal Ulcer/therapy
Duodenum/blood supply
Embolization, Therapeutic
Endoscopy, Gastrointestinal
Female
Femoral Artery
Humans
Infusions, Intra-Arterial
Liver Neoplasms/drug therapy
Liver Neoplasms/secondary
Male
Middle Aged
Mitomycin/administration & dosage
Mitomycin/adverse effects
Nitrosourea Compounds/administration & dosage
Nitrosourea Compounds/adverse effects
Organophosphorus Compounds/administration & dosage
Organophosphorus Compounds/adverse effects
Organoplatinum Compounds/administration & dosage
Organoplatinum Compounds/adverse effects
Stomach/blood supply
Stomach Ulcer/chemically induced
Stomach Ulcer/therapy
Treatment Outcome
Radiology Nuclear Medicine and imaging
General Medicine
Artery
medicine.anatomical_structure
medicine
Gastroduodenal artery
medicine.artery
Embolization
medicine.medical_treatment
Surgery
medicine.medical_specialty
Catheter
Esophagogastroduodenoscopy
medicine.diagnostic_test
business.industry
business
Interventional radiology
Hepatic arterial infusion
Radiology
Right gastric artery
Źródło:
European Radiology, vol. 17, no. 8, pp. 2160-2165
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca3c53d492ea57d57dd6b8f86bb3204
http://doc.rero.ch/record/319170/files/330_2006_Article_552.pdf
Tytuł:
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Autorzy:
Martin, Miguel
Holmes, Frankie A
Ejlertsen, Bent
Delaloge, Suzette
Moy, Beverly
Iwata, Hiroji
von Minckwitz, Gunter
Chia, Stephen K L
Mansi, Janine
Barrios, Carlos H
Gnant, Michael
Tomašević, Zorica
Denduluri, Neelima
Šeparović, Robert
Gokmen, Erhan
Bashford, Anna
Ruiz Borrego, Manuel
Kim, Sung-Bae
Jakobsen, Erik Hugger
Ciceniene, Audrone
Inoue, Kenichi
Overkamp, Friedrich
Heijns, Joan B
Armstrong, Anne C
Link, John S
Joy, Anil Abraham
Bryce, Richard
Wong, Alvin
Moran, Susan
Yao, Bin
Xu, Feng
Auerbach, Alan
Buyse, Marc
Chan, Arlene
Harvey, Vernon
Tomek, Rudolf
Robert, Nicholas J.
Gore, Ira
Smith, John W.
Masuda, Norikazu
Di Sean Kendall, S.
Harker, William Graydon
Petrakova, Katarina
Guerrero Zotano, Angel
Simon, Amparo Ruiz
Konstantinovic, Zora Neskovic
Iannotti, Nicholas O.
Tassone, Pierfrancesco
Rodriguez, Gladys I.
Jáñez Martinez, Noelia
Crespo Massieu, Carmen
Smickoska, Snezana
Somali, Isil
Yilmaz, Ugur
Alonso, Mirta Garcia
Rosales, Adolfo Murias
Cold, Soeren
Knoop, Ann Soegaard
Patt, Debra
Hellerstedt, Beth A.
Morales Murillo, Serafin
Mayer, Ingrid A.
Means-Powell, Julie Ann
Hui, Rina
Senecal, Francis M.
De Boer, Richard Hendry
Shen, Zhenzhou
Luczak, Adam Andrzej
Chui, Joanna W.Y.
Tsang, Janice Wing-hang
Lang, Istvan
Rai, Yoshiaki
Hozumi, Yasuo
Ten Tije, Albert J.
Bhandari, Manish
Osborne, Cynthia R.C.
Ohtani, Shoichiro
Higaki, Kenji
Watanabe, Kenichi
Taguchi, Kazunori
Takahashi, Masato
Filipovic, Sladjana
Hansen, Vincent L.
Rao, Vijayarama Phooshkooru
Gupta, Manish
Petrov, Petar
Coudert, Bruno
Vojnovic, Zeljko
Polya, Zsofia
Miyaki, Toshiko
Yamamoto, Naohito
Brincat, Stephen
Lesniewski-Kmak, Krzysztof
Chmielowska, Ewa
Birhiray, Ruemu E.
Citron, Marc L.
Papish, Steven William
Berry, William R.
Langkjer, Sven Tyge
Garcia Sáenz, José Angel
Arance, Ana Maria
Efrat, Noa
Sarosiek, Tomasz
Grzeda, Lukasz
Manalo, Yvonne
Smith, Julie C.
Vaziri, Irfan
Healey, Tabitha
Rahim, Yasmin
Luk, Cynthia
Dingle, Brian
Franco, Sandra
Sorensen, Peter Grundtvig
Anand, Anjana
Khan, Sarah
Fountzilas, George
Aogi, Kenjiro
Shimizu, Satoru
Mikulova, Milada
Spanik, Stanislav
Somer, Robert A.
Flynn, Patrick J.
Coward, Jermaine
Mainwaring, Paul
Jerusalem, Guy
Segura-Ojezzar, Carine
Levy, Christelle
Delozier, Thierry
Khayat, David
Coleman, Robert E.
Rolles, Martin J.
Maisano, Robert
Nardi, Mario
Ito, Yoshinori
Yumuk, Perran Fulden
Basaran, Gul
Serdar Turhal, Nazim
Wilkinson, Mary J.
Green, Nathan B.
Sidrys, Algis P.
Hallmeyer, Sigrun
Testori, Douglas J.
Sridhar, Srikala
Chang, Jose
Sun, Qiang
Jara-Sanchez, Carlos
Rubio, Xabier
Garrido, Maria Lomas
De La Haba Rodriguez, Juan Rafael
Perello Martorell, Antonia
Avelia Mestre, Antoni
Rifa Ferrer, Julio
del Barco Berron, Sonia
Nagy, Zsuzsanna
Tanaka, Maki
Im, Young-Hyuck
Carroll, Robert R.
Dickerson, Laura C.
Mace, Joseph R.
Rivera, Ragene
Klein, Leonard M.
Ruxer, Robert
Wilks, Sharon T.
Kotasek, Dusan
Popov, Vasil
Taskova, Violina
Marinova-Venkova, Violetka
Timcheva, Constanta
Desbiens, Christine
Ayoub, Jean-Pierre
Grenier, Debjani
Marschner, Norbert
Tesch, Hans
Lueck, Hans-Joachim
Janssen, Jan
Schwaner, Ingo
Wahlstrom, Stine
Brix, Eva Harder
Vallentin, Susanne
Kristensen, Dan
Andreeva, Anna
Glavicic, Vesna
Calvo Plaza, Isabel
Anton Torres, Antonio
Veyret, Corinne
Bergerat, Jean-Pierre
Bourbouloux, Emmanuelle
Ella, Wendy Ann
Algurafi, Hafiz
Robinson, Anne
Kim, Seung Jin
Taguchi, Tetsuya
Juozaityte, Elona
Madretsma, Stanley
Radema, Sandra
Czerniawska-Meier, Malgorzata
Rogowski, Wojciech
Wagnerova, Maria
Richards, Donald A.
Tan-Chiu, Elizabeth
Vasileios, Asskikis
Henderson, Charles Arthur
Holden, Viran Roger
Wang, Xiaojia
Tong, Zhongsheng
Yang, Junlan
Gonzalez, Manuel Enrique
Rezai, Mahdi
Hackmann, John
de Dueñas, Eduardo Martinez
de las Heras, Begoña Bermejo
Dourthe, Louis Marie
Chocteau-Bouju, Dorothee
Bougnoux, Philippe
Kakolyris, Stylianos
Kalofonos, Haralabos
Pectasidis, Dimitrios
Ng, Ting Ying
Pajkos, Gabor
Somogyine, Eva Ezer
Tonini, Giuseppe
Giuffrida, Dario
Takao, Shintaro
Ishitobi, Makoto
Inaji, Hideo
Tokuda, Yutaka
Wozniak, Katarzyna
Lungulescu, Dan
Lu, Yen-Shen
Chang, King-Jen
Hill, Julian
Croot, Christopher Charles
Dekker, Albert
Belman, Neil D.
Conde, Miguel
Michaelson, Richard A.
Kemmer, Kathleen
Chui, Stephen
Luoh, Shiuh-Wen
Nahum, Kenneth
Greenspan, Andrew R.
Nichols, Joni C.
Encarnacion, Carlos A.
Niederman, Thomas M.J.
Lee, Theresa
Alexander, Roland
Gordon, Robert
Tomova, Antoanet
Rauch, Daniel
Popescu, Razvan Andrei
Rojas, Gustavo Adolfo
Vanasek, Jaroslav
Neunhoeffer, Tanja
Barinoff, Jana
Graffunder, Gerd
Wolfgang, Abenhardt
Bojko, Peter
Heinrich, Bernhard
von der Assen, Albert
Antonovic, Bogovic Jurij
Adrian, Lene
Ramos Vazquez, Manuel
Gonzalez Santiago, Santiago
Dieras, Veronique
Bishop, Jill Mercia
Perren, Timothy John
Varthalitis, Ioannis
Mavroudis, Dimitris
Georgoulias, Vassilis
Chow, Louis W.C.
Yau, Chung Cheung Thomas
Liang, Raymond Hin-Suen
Pikó, Béla
Wéber, Agnes
Kaufman, Bella
Drumea, Karen
Nuzzo, Francesco
De Matteis, Andrea
Carteni, Giacomo
Tokunaga, Eriko
Ishida, Mayumi
Ohno, Shinji
Sato, Nobuaki
Kuroi, Katsumasa
Nishimura, Reiki
Watanabe, Junichiro
Choi, Yoon Ji
Park, Kyong Hwa
Wojtukiewicz, Marek
Jassem, Jacek
Loman, Niklas
Askoy, Sercan
Altundag, Mustafa Kadri
Saip, Pinar
Ali, Muhammad Amjad
Wade, James Lloyd
Chien, Amy Jo
Brandt, Debra
Novik, Yelena
Jani, Chirag
Rice, Robert L.
Gaffar, Yousuf A. R
Keaton, Mark R.
Bajaj, Rajesh
Kimmick, Gretchen
Campbell, David
Turnquest, Theodore
Lucas, Sideras
Dube, Pierre
Xu, Binghe
Schilling, Joerg
Apel, Klaus
Vestlev, Peter Michael
Jensen, Brita Bjerregaard
Haahr, Vera
Lescure, Alvaro Rodriguez
Grana Suarez, Begona
Saura Manich, Cristina
Jacquin, Jean-Philippe
Samreen, Ahmed
Boiangiu, Ion
Dank, Magdolna
Falci, Cristina
Jirillo, Antonio
Cinieri, Saverio
Ueno, Takayuki
Sato, Fumiaki
Yamashiro, Hiroyasu
Sugie, Tomoharu
Lee, Keun Seok
Ro, Jung Sil
Park, In Hae
Bustam, Anita Zarina
Suszko-Kazarnowicz, Malgorzata
Piktel, Artur
Krzemieniecki, Krzysztof
Iorga, Polizenia Georgeta
Yap, Yoon Sim
Kakalejcik, Marian
Sevinc, Alper
Ozguroglu, Mustafa
Chen, Shin-Cheh
Greenberg, Richard H.
Eisemann, Allan Daniel
Droder, Robert
Abbasi, M. Rashid
Vaysburd, Marina
Caldera, Humberto Jose
Haley, Barbara Bacsik
Robin, Erwin
Inhorn, Roger C.
Hufnagel, David
Kenyon, Peter D.
Spremulli, Ellen
Silverman, Paula
Jain, Sharad
Weigand, Robert
Mebis, Jeroen
Koynova, Tatyana
Lesperance, Bernard
Prausova, Jana
Kohne, Claus-Henning
Schneeweiss, Andreas
Jackisch, Christian
Fuxius, Stefan
Cubedo Cervera, Ricardo
Urruticoechea Ribate, Ander
Pernas Simon, Sonia
Valero Gallego, Jose
Arcusa Lanza, Angels
del Pilar Alvarez, Maria
Florian Gerico, Jesus
Cany, Laurent
Stebbing, Justin
Labudovic, Dejan
Gugic, Damir
Vrbanec, Damir
Roila, Fausto
Barni, Sandro
Bidoli, Paolo
Mukai, Hirofumi
Bermudez, Vanessa
Eniu, Alexandru
Mirtsching, Barry C.
Ibrahim, Emad
Trey, Joan
Hergenroeder, Paul Francis
Mahmood, Aftab
Gonzalez, Anneliese
Kaplan, Edward H.
Ban, Stacy
Patel, Dhimant
Clowney, Billy
Hoelzer, Karen
Schwartz, Garry H.
Salkeni, Mohamed
Abraham, Jame
Narula, Sunil
Jabboury, Khaled
Mocharnuk, Robert Scott
McDonough, Richard H.
Sikes, David H.
Kawanchi, Ronald H.
Schlabach, Larry
McCachren, Samuel Spence
Cosgriff, Thomas M.
Dreisbach, Luke
DeMichele, Angela
Pawl, Lawrence
Lucas, Jennifer
Shinn, Lowell C.
Alkhouri, Nabiel
Monga, Manish
Lindquist, Deborah L.
Anderson, Thomas C.
Khurshid, Humera
Witherby, Sabrina
Erickson, Nicholette
Traynor, Ann
Bose, Ron
Pluard, Timothy J.
Jones, Michael C.
Prakash, Sucharu
Volterra, Fabio
Capo, Gerardo
Flaherty, Lawrence E.
Gartner, Elaina
Baidas, Said
Okazaki, Ian
Nguyen, Bichlien
Rakowski, Thomas
Oliff, Ira
Leach, Joseph W.
Anderson, Daniel
Kubiak, Kendra
Tsai, Michaela
Vroman, Philippe
Deleu, Ines
Lybaert, Willem
Borms, Marleen
Couture, Felix
Wilson, Jonathan J.
Hunt, Gordon
Holland, David R.
Mingrone, Walter
Wang, Shusen
Liu, Donggeng
Jiang, Zefei
Benesova, Vera
Smakal, Martin
Garnolova, Petra
Vesper, Anne-Sophie
Neumann, Monika
Janni, Wolfgang
Liedtke, Cornelia
Fischer, Dorothea
Grischke, Eva-Maria
Seeger, Dietmar
Moebus, Volker
Prechtl, Anita
Carlos Camara Toral, Juan
Sanchez Munoz, Alfonso
Gonzalez Jimenez, Sonia
Cassinello Espinosa, Javier
Cirauqui, Beatriz
Margeli Vila, Mireia
Batista Lopez, Norberto
Chacon Lopez-Muniz, Jose Ignacio
de la Cruz Mora, Miguel Angel
Mailliez, Audrey
Vanlemmens, Laurence
Pouessel, Damien
Espie, Marc
Conibear, John
Roylance, Rebecca
Harnett, Adrian
Geffen, David
Ruggeri, Enzo Maria
Gamucci, Teresa
Van Groeningen, Cees J.
Banas, Renata
Alkis, Necati
Hou, Ming-Feng
Krie, Amy K.
Vrindavanam, Nandagopal S.
Howard, Orion M.
Citrin, Dennis
Morginstin, Mark S.
Desai, Ajit
Sanchez, Ines J.
Nixon, David Allen
Beatty, Patrick G.
Edmiston, Kathryn
McLaughlin, Marilyn
Eneman, Jonathan D.
Lynch, Cynthia A.
O'Brien, Edward
Call, Justin A.
Lanier, Keith S.
Conlin, Alison
Brooks, Donald J.
McIntyre, Kristi
Saltzman, Marc A.
Castine, Michael J.
Ortega, Gregory L.
Choi, Young M.
Reynolds, Craig H.
Brescia, Frankie Ann
Kramer, Rita
Kohn, Aimee D.
Micha, John P.
Rhee, Jessica M.
Shah, Satish
Riseberg, David A.
Patterson, William Kevin
Salmon, Jean-Paul
Andre, Chantal
Bols, Alain
D'hondt, Randal
Luce, Sylvie
Nouwynck, Claire
Pelgrims, Gino
Richard, Vincent
Verschuere, Johan
Geldhof, Kurt
Caspar, Clemens
Luo, Rongcheng
Bednarik, Otakar
Schwedler, Kathrin
Schmidt, Marcus
Neumeister, Romy
Bischoff, Joachim
Rack, Brigitte
Repp, Roland
Fries, Stefan
Adrion, Ralf
Schulz, Volker
Klare, Peter
Danei, Mahmoud
Ossenbuhl, Dirk
Kusche, Jakob Manfred
Griesinger, Frank
Baena Canada, Jose Manuel
Martinez del Prado, Purificacion
Machover, David
Mayeur, Didier
Trufflandier, Nathalie
Delecroix, Valerie
Mousseau, Mireille
Mouret-Reynier, Marie-Ange
Nabholtz, Jean-Marc
Chetiyawardana, Anula D.
Papandreou, Christos
Hornyak, Lajos
Faluhelyi, Zsolt
Simo, Erzsebet
Di Palma, Mario
Cognetti, Francesco
Gorzegno, Gabriella
Dogliotti, Luigi
Gridelli, Cesare
Falcone, Alfredo
Soto Parra, Hector
Buscarino, Calogero
Im, Seock-Ah
Sanchez Llamas, Benito
Dercksen, Wouter
Erdkamp, Franciscus
Ruit, Jan B.
Braun, Hans
Portielje, Joanneke E.A.
Ciltas, Aydin
Buyukberber, Suleyman
Benekli, Mustafa
Zahalsky, Andrew J.
Jaslow, Rebecca
Thomas, Gary W.
Maini, Archana
Wiznitzer, Israel
Khojasteh, Ali
Francisco Gonzalez, Manuel
Kong, Lynn R.
Padmanabhan, Aruna
Conkright, William A.
Swain, Sandra M.
Faig, Douglas E.
Jain, Kirti
Yanagihara, Ronald H.
Ottaviano, Yvonne
Delmas, Andrew
Steele, Heather A.
Rainey, Gordon K.
Harris, Penelope J.
Burris, Jason K.
Rupard, Erik J.
Tan, Esther
Whitworth, Pat W.
Bova, Abby R.
Anderson, Ian C.
Shirinian, Mihran
Tin-u, Caesar
O'Rourke, Timothy J.
Roberts, Michael S.
Francisco, Michael
Pierson, A. Scott
Byeff, Peter D.
Kovach, Peter A.
Caton, John R.
Rarick, Mark Urban
Schimidt, William G.
Stopeck, Alison T.
Swart, Rachel
Carrillo Flores, Maria Regina
Alemany, Carlos A.
Lozada, Brennely
Weinstein, Paul L.
Wang, Wei
Porubcin, Michael
Ellison, David M.
Geils, George F.
Rivera, Edgardo
Charif, Mahmoud
Pokaż więcej
Temat:
Administration, Oral
Adult
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Chemotherapy, Adjuvant
Disease-Free Survival
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Japan
Kaplan-Meier Estimate
Mastectomy
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Proportional Hazards Models
Quinolines
Receptor, ErbB-2
Risk Assessment
Survival Analysis
Time Factors
Trastuzumab
Treatment Outcome
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Antibodies, Monoclonal, Humanized/adverse effects
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Breast Neoplasms/drug therapy
Mastectomy/methods
Neoplasm Invasiveness/pathology
Quinolines/administration & dosage
Receptor, ErbB-2/metabolism
Trastuzumab/administration & dosage
Oncology
medicine.drug
medicine
Regimen
Adjuvant therapy
Surgery
medicine.medical_specialty
business.industry
business
Neratinib
Breast cancer
medicine.disease
Clinical trial
Internal medicine
Intention-to-treat analysis
Placebo
Źródło:
Martin, M, Holmes, F A, Ejlertsen, B, Delaloge, S, Moy, B, Iwata, H, von Minckwitz, G, Chia, S K L, Mansi, J, Barrios, C H, Gnant, M, Tomašević, Z, Denduluri, N, Šeparović, R, Gokmen, E, Bashford, A, Ruiz Borrego, M, Kim, S-B, Jakobsen, E H, Ciceniene, A, Inoue, K, Overkamp, F, Heijns, J B, Armstrong, A C, Link, J S, Joy, A A, Bryce, R, Wong, A, Moran, S, Yao, B, Xu, F, Auerbach, A, Buyse, M, Chan, A, Langkjer, S T & ExteNET Study Group (Sven Tyge Langkjer; member) 2017, ' Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. ', The Lancet Oncology, vol. 18, no. 12, pp. 1688-1700 . https://doi.org/10.1016/S1470-2045(17)30717-9
ExteNET Study Group 2017, ' Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET) : 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet Oncology, vol. 18, no. 12, pp. 1688-1700 . https://doi.org/10.1016/S1470-2045(17)30717-9
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa781401cf7429875a03dfc024ffce82
https://pure.au.dk/portal/da/publications/neratinib-after-trastuzumabbased-adjuvant-therapy-in-her2positive-breast-cancer-extenet-5year-analysis-of-a-randomised-doubleblind-placebocontrolled-phase-3-trial(c0396548-3806-46db-8e66-0886d28724ea).html
Tytuł:
Choosing the right strategy based on individualized treatment effect predictions: Combination versus sequential chemotherapy in patients with metastatic colorectal cancer
Autorzy:
Matthew T. Seymour
Cornelis J. A. Punt
Frank L.J. Visseren
R.C.M. van Kruijsdijk
Johannes J M Kwakman
Miriam Koopman
Sjoerd G. Elias
Angela M. Meade
Pokaż więcej
Temat:
Oncology
Hematology
Nomogram
Randomized controlled trial
law.invention
law
Chemotherapy regimen
Internal medicine
medicine.medical_specialty
medicine
Disease
Prognostic variable
Cancer
medicine.disease
business.industry
business
Individualized treatment
Colorectal cancer
Radiology Nuclear Medicine and imaging
General Medicine
Logistic regression
Combination chemotherapy
Aged
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Capecitabine/administration & dosage
Colorectal Neoplasms/drug therapy
Drug Administration Schedule
Female
Humans
Irinotecan/administration & dosage
Male
Middle Aged
Oxaliplatin/administration & dosage
Precision Medicine/methods
Journal Article
Randomized Controlled Trial
Medicine
Pharmacology
Biotechnology
69999 Biological Sciences not elsewhere classified
FOS: Biological sciences
80699 Information Systems not elsewhere classified
FOS: Computer and information sciences
19999 Mathematical Sciences not elsewhere classified
FOS: Mathematics
Plant Biology
Źródło:
Acta Oncologica, 58(3), 326. Informa Healthcare
Acta Oncologica, 58(3), 326-333. Informa Healthcare
Opis pliku:
image/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df89b015e8150bef91ac13576c30fed
https://api.elsevier.com/content/article/PII:S0923753419588032?httpAccept=text/xml
Tytuł:
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
Autorzy:
Amélie Deleporte
Stéphane Holbrechts
Thomas Guiot
Camilo Garcia
Lieveke Ameye
Irina Vierasu
Thierry Delaunoit
Erwin Woff
Renaud Lhommel
Marc Van den Eynde
Patrick Flamen
Raphaël Maréchal
Alain Hendlisz
Gauthier Demolin
Namur Gauthier
Pokaż więcej
Temat:
Original Article
Early metabolic response assessment
FDG PET-CT
Tumoral heterogeneity
Metastatic colorectal cancer
Targeted therapy
Radiology Nuclear Medicine and imaging
General Medicine
Tumour response
Oncology
medicine.medical_specialty
medicine
Predictive value
business.industry
business
Capecitabine
medicine.drug
Fdg pet ct
Internal medicine
Colorectal cancer
medicine.disease
Response assessment
Sorafenib
medicine.medical_treatment
Imagerie médicale, radiologie, tomographie
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Capecitabine -- administration & dosage
Colorectal Neoplasms -- diagnostic imaging -- drug therapy -- secondary
Drug Monitoring -- methods
Female
Fluorodeoxyglucose F18 -- pharmacokinetics
Humans
Male
Middle Aged
Molecular Targeted Therapy -- methods
Niacinamide -- administration & dosage -- analogs & derivatives
Phenylurea Compounds -- administration & dosage
Positron Emission Tomography Computed Tomography -- methods
Radiopharmaceuticals -- pharmacokinetics
Reproducibility of Results
Sensitivity and Specificity
Treatment Outcome
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, p. 1792-1801 (2016)
European journal of nuclear medicine and molecular imaging, 43 (10
Opis pliku:
1 full-text file(s): application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0aa1f3a5363635b991f75146123099
http://europepmc.org/articles/PMC4969337
Tytuł:
First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment
Autorzy:
Munier, Francis L
Mosimann, Pascal
Puccinelli, Francesco
Gaillard, Marie-Claire
Stathopoulos, Christina
Houghton, Susan
Bergin, Ciara
Beck-Popovic, Maja
Pokaż więcej
Temat:
Aftercare
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Carboplatin/administration & dosage
Child
Child, Preschool
Etoposide/administration & dosage
Humans
Infant
Infusions, Intra-Arterial
Infusions, Intravenous
Melphalan/administration & dosage
Retinal Neoplasms/drug therapy
Retinoblastoma/drug therapy
Retrospective Studies
Salvage Therapy/methods
Treatment Outcome
Vision Disorders/prevention & control
Child health (paediatrics)
Neoplasia
Retina
Treatment Medical
Clinical Science
Cellular and Molecular Neuroscience
Sensory Systems
Ophthalmology
Etoposide
medicine.drug
medicine
business.industry
business
Surgery
medicine.medical_specialty
Chemotherapy
medicine.medical_treatment
Visual acuity
medicine.symptom
Unilateral Retinoblastoma
Retrospective cohort study
Melphalan
Carboplatin
chemistry.chemical_compound
chemistry
Salvage therapy
Źródło:
The British journal of ophthalmology, vol. 101, no. 8, pp. 1086-1093
The British Journal of Ophthalmology
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d75fe9c376208634d42411c4523ad3
https://serval.unil.ch/notice/serval:BIB_E4AC4FB222A2
Tytuł:
ICORG 10-14:NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
Autorzy:
Reynolds, J.V.
Preston, S.R.
O’neill, B.
Baeksgaard, L.
Griffin, S.M.
Mariette, C.
Cuffe, S.
Cunningham, M.
Crosby, T.
Parker, I.
Hofland, K.
Hanna, G.
Svendsen, L.B.
Donohoe, C.L.
Muldoon, C.
O’toole, D.
Johnson, C.
Ravi, N.
Jones, G.
Corkhill, A.K.
Illsley, M.
Mellor, J.
Lee, K.
Dib, M.
Marchesin, V.
Cunnane, M.
Scott, K.
Lawner, P.
Warren, S.
O’Reilly, S.
O’Dowd, G.
Leonard, G.
Hennessy, B.
Mc Dermott, R.
Pokaż więcej
Temat:
Adenocarcinoma/drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Carboplatin/administration & dosage
Disease-Free Survival
Esophageal Neoplasms/drug therapy
Esophagogastric Junction/drug effects
Female
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local/drug therapy
Paclitaxel/administration & dosage
Quality of Life
Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Oesophageal
Oesophagogastric junction
Adenocarcinoma
Neoadjuvant chemoradiation therapy
Neoadjuvant chemotherapy
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282
Cancer Research
Genetics
Oncology
Surgery
medicine.medical_specialty
medicine
Neoadjuvant therapy
medicine.medical_treatment
Stage (cooking)
business.industry
business
Regimen
Carboplatin
chemistry.chemical_compound
chemistry
Clinical endpoint
Randomized controlled trial
law.invention
law
Clinical research
Radiation therapy
Study Protocol
Źródło:
Reynolds, J V, Preston, S R, O'Neill, B, Baeksgaard, L, Griffin, S M, Mariette, C, Cuffe, S, Cunningham, M, Crosby, T, Parker, I, Hofland, K, Hanna, G, Svendsen, L B, Donohoe, C L, Muldoon, C, O'Toole, D, Johnson, C, Ravi, N, Jones, G, Corkhill, A K, Illsley, M, Mellor, J, Lee, K, Dib, M, Marchesin, V, Cunnane, M, Scott, K, Lawner, P, Warren, S, O'Reilly, S, O'Dowd, G, Leonard, G, Hennessy, B & Dermott, R M 2017, ' ICORG 10-14 : NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) ', B M C Cancer, vol. 17, 401 . https://doi.org/10.1186/s12885-017-3386-2
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Cancer
Opis pliku:
application/pdf; text
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b993161e8515b06273bfc9a1e222ce7
https://curis.ku.dk/portal/da/publications/icorg-1014(31db130e-532e-4195-a5bb-f2b3044ce10c).html
Tytuł:
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma:An international multicenter study of 1532 patients treated with chemoimmunotherapy
Autorzy:
Maja Bech Juul
Jakob Werner Hansen
Diego Villa
Staffan Holmberg
Tarec Christoffer El-Galaly
Chan Yoon Cheah
Karen Juul Mylam
Sabrina Cordua
Peter de Nully Brown
Martin Hutchings
Kerry J. Savage
Joseph M. Connors
Sally Barrington
N. G. Mikhaeel
Daniel J. Smith
Martin Bøgsted
Hans Erik Johnsen
John F. Seymour
Kristina Buchardi Jensen
Thomas Stauffer Larsen
Michael Roost Clausen
Thomas Yssing Michaelsen
Laurie H. Sehn
Kirsty Rady
Pokaż więcej
Temat:
Diffuse large B-cell lymphoma
PET/CT
CNS-IPI
CNS relapse
Secondary CNS involvement
CNS prophylaxis
Prognosis
PET/CT imaging
extra nodal
Cancer Research
Oncology
Internal medicine
medicine.medical_specialty
medicine
Surgery
medicine.disease
Aggressive lymphoma
Rituximab
medicine.drug
Chemoimmunotherapy
business.industry
business
Stage (cooking)
Cumulative incidence
International Prognostic Index
Retrospective cohort study
Immunotherapy/methods
Humans
Middle Aged
Antibodies, Monoclonal, Murine-Derived/administration & dosage
Male
Central Nervous System Neoplasms/diagnostic imaging
Vincristine/administration & dosage
Lymphoma, Large B-Cell, Diffuse/diagnostic imaging
Young Adult
Aged, 80 and over
Adult
Retrospective Studies
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Neoplasm Recurrence, Local/diagnostic imaging
Risk Factors
Prednisone/administration & dosage
Treatment Outcome
Combined Modality Therapy
Positron Emission Tomography Computed Tomography
Cyclophosphamide/administration & dosage
Adolescent
Doxorubicin/administration & dosage
Aged
Journal Article
Źródło:
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Mylam, K J, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European journal of cancer (Oxford, England : 1990), vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Buchardi Jensen, K, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::962cd94c84c0f71a3ed502c7f58bb054
https://kclpure.kcl.ac.uk/portal/en/publications/the-number-of-extranodal-sites-assessed-by-petct-scan-is-a-powerful-predictor-of-cns-relapse-for-patients-with-diffuse-large-bcell-lymphoma(bd3e5f8f-f188-4562-a9ee-1ba4e01cc36c).html
Tytuł:
Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors
Autorzy:
Pascal Wolter
Alain Hendlisz
Martina Uttenreuther-Fischer
Herlinde Dumez
Ahmad Awada
Patrick Schöffski
Martine Piccart
Frank Fleischer
T. Besse-Hammer
Peter Stopfer
Pokaż więcej
Temat:
Phase I Studies
Phase I
BIBW 2992
Afatinib
Epidermal growth factor receptor
Tyrosine kinase inhibitor
Pharmacokinetics
Science & Technology
Life Sciences & Biomedicine
Oncology
Pharmacology & Pharmacy
CELL LUNG-CANCER
KINASE INHIBITOR
GEFITINIB
ERLOTINIB
TRIAL
CARBOPLATIN
PACLITAXEL
BIBW-2992
LINES
Cancérologie
Adult
Aged
Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects -- pharmacokinetics
Drug Administration Schedule
Female
Gastrointestinal Diseases -- chemically induced
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms -- blood -- drug therapy
Quinazolines -- administration & dosage -- adverse effects -- pharmacokinetics
Skin Diseases -- chemically induced
Taxoids -- administration & dosage -- adverse effects -- pharmacokinetics
Pharmacology (medical)
Pharmacology
medicine.medical_specialty
medicine
Toxicity
Tyrosine-kinase inhibitor
medicine.drug_class
business.industry
business
Stomatitis
medicine.disease
Rash
medicine.symptom
medicine.drug
Adverse effect
Internal medicine
Docetaxel
neoplasms
Źródło:
Investigational New Drugs
Investigational new drugs, 31 (3
Opis pliku:
Print-Electronic; 1 full-text file(s): application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed9ba982df0332356cd898f91dd30e4
http://europepmc.org/articles/PMC3644400
Tytuł:
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction:Results from the UK NCRI AML17 trial in 1206 patients
Autorzy:
Burnett, Alan K.
Russell, Nigel H.
Hills, Robert K.
Kell, Jonathan
Cavenagh, Jamie
Kjeldsen, Lars
McMullin, Mary-Frances
Cahalin, Paul
Dennis, Mike
Friis, Lone
Thomas, Ian F.
Milligan, Don
Clark, Richard E.
Pokaż więcej
Temat:
Adolescent
Adult
Aged
Antibiotics, Antineoplastic/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Cytarabine/administration & dosage
Daunorubicin/administration & dosage
Dose-Response Relationship, Drug
Female
Humans
Induction Chemotherapy/methods
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute/drug therapy
Male
Middle Aged
Young Adult
Cell Biology
Hematology
Immunology
Biochemistry
Medicine
business.industry
business
Internal medicine
medicine.medical_specialty
Randomized controlled trial
law.invention
law
Surgery
Gastroenterology
Hazard ratio
Daunorubicin
medicine.drug
Odds ratio
Cytarabine
Subgroup analysis
Chemotherapy
medicine.medical_treatment
Induction chemotherapy
Clinical Trials and Observations
Źródło:
The UK NCRI AML Study Group 2015, ' A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction : Results from the UK NCRI AML17 trial in 1206 patients ', Blood, vol. 125, no. 25, pp. 3878-3885 . https://doi.org/10.1182/blood-2015-01-623447
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f923b34a94adc63a7bb88d571144b48b
https://portal.findresearcher.sdu.dk/da/publications/823c2601-ae67-467f-b324-54a36712ae98
Tytuł:
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin:Results from the DAHANCA 18 phase II study
Autorzy:
Bentzen, Jens
Toustrup, Kasper
Eriksen, Jesper Grau
Primdahl, Hanne
Andersen, Lisbeth Juhler
Overgaard, Jens
Pokaż więcej
Temat:
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Carcinoma, Squamous Cell/drug therapy
Chemoradiotherapy/adverse effects
Cisplatin/administration & dosage
Disease-Free Survival
Female
Head and Neck Neoplasms/drug therapy
Humans
Male
Middle Aged
Nimorazole/administration & dosage
Squamous Cell Carcinoma of Head and Neck
Radiology Nuclear Medicine and imaging
Oncology
Hematology
General Medicine
Concomitant
Head and neck cancer
medicine.disease
medicine
Radiation therapy
medicine.medical_treatment
business.industry
business
Head and neck squamous-cell carcinoma
medicine.medical_specialty
Internal medicine
Phases of clinical research
Carcinoma
DAHANCA
Nimorazole
medicine.drug
Źródło:
Bentzen, J, Toustrup, K, Eriksen, J G, Primdahl, H, Andersen, L J & Overgaard, J 2015, ' Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin : Results from the DAHANCA 18 phase II study ', Acta Oncologica, vol. 54, no. 7, pp. 1001-1007 . https://doi.org/10.3109/0284186X.2014.992547
Bentzen, J, Toustrup, K, Eriksen, J G, Primdahl, H, Andersen, L J & Overgaard, J 2015, ' Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study ', Acta Oncologica, vol. 54, no. 7, pp. 1001-7 . https://doi.org/10.3109/0284186X.2014.992547
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::872f44355777cb173fc95c1568eb61cc
https://vbn.aau.dk/da/publications/04f42206-cd3d-47ac-8bdc-11d2201a794a
Tytuł:
The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells
Autorzy:
Hosein, Abdel Nasser
Lim, Yi Chieh
Day, Bryan
Stringer, Brett
Rose, Stephen
Head, Richard
Cosgrove, Leah
Sminia, Peter
Fay, Michael
Martin, Jennifer H
Pokaż więcej
Temat:
glioblastoma
valproic acid
radiosensitisation
Animals
Antineoplastic Agents/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Brain Neoplasms/drug therapy
Cell Survival/drug effects
Cells, Cultured
Chemoradiotherapy/methods
DNA Methylation
DNA Modification Methylases/genetics
DNA Repair Enzymes/genetics
Dacarbazine/administration & dosage
Dose-Response Relationship, Drug
Gene Expression Profiling
Glioblastoma/drug therapy
Humans
Mice, Inbred NOD
Mice, SCID
Microarray Analysis
Neoplasm Transplantation
Promoter Regions, Genetic
Radiation-Sensitizing Agents/administration & dosage
Tumor Suppressor Proteins/genetics
Valproic Acid/administration & dosage
Cancer Research
Clinical Neurology
Neurology
Oncology
Valproic Acid
medicine.drug
medicine
Pharmacology
DNA methylation
In vitro
In vivo
business.industry
business
Temozolomide
Gene expression profiling
Microarray analysis techniques
Dose–response relationship
Cells
Cultured
Dose-Response Relationship
Drug
Mice
Inbred NOD
SCID
Promoter Regions
Genetic
lipids (amino acids, peptides, and proteins)
Źródło:
Journal of Neuro-Oncology, 122(2), 263-271. Kluwer Academic Publishers
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d598ba1e81a0fbe29ea450812f16d6a

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz